NCT04976764 is a clinical trial in Cirrhosis, Liver, sponsored by The Affiliated Hospital of Qingdao University.

Who is sponsoring NCT04976764?

NCT04976764 is sponsored by The Affiliated Hospital of Qingdao University.

What condition does NCT04976764 study?

NCT04976764 studies Cirrhosis, Liver.

Is NCT04976764 still recruiting?

NCT04976764 is currently status unknown. Last updated 26 July 2021.

Last reviewed 2021-07-26 · How we verify

NCT04976764

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Correlation Between Cirrhotic Cardiomyopathy and Perioperative Cardiovascular Events in Liver Transplantation

Status unknown Last updated 26 July 2021

What this trial tests

trial in Cirrhosis, Liver in 850 participants. Status unknown.

Timeline

1 August 2021

Primary endpoint
1 August 2022

1 September 2023

Quick facts

Lead sponsor	The Affiliated Hospital of Qingdao University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	850
Start date	1 August 2021
Primary completion	1 August 2022
Estimated completion	1 September 2023

Conditions studied

Cirrhosis, Liver — all drugs for Cirrhosis, Liver →

Sponsor

The Affiliated Hospital of Qingdao University

Who can join

Adults 18 to 80, any sex, with Cirrhosis, Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver transplantation is an effective treatment for end-stage liver disease. Cardiovascular complications are the common causes of death in liver transplant recipients. The presence of cirrhosis cardiomyopathy has a potential impact on the prognosis of liver transplant recipients. Therefore, it is important to identify the high risk factors with cirrhotic cardiomyopathy before transplantation, so as to intervene earlier and improve the prognosis of patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The predictive value of revised diastolic dysfunction in outcomes of liver transplantation: A propensity score matching analysis.
Bi S, Jiang Y, Zhao W, Niu X, et al · · 2022 · cited 3× · PMID 36684235 · DOI 10.3389/fsurg.2022.1072908

Verify or expand the search:

Other recruiting trials for Cirrhosis, Liver

Currently open trials in the same condition.

NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
NCT07051369 — Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound · active not recruiting
NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting

Other The Affiliated Hospital of Qingdao University trials

Trials by the same sponsor.

NCT07485920 — A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedani · Phase 4 · not yet recruiting
NCT07465861 — Bed Rest Duration and Outcomes in Endoscopic Skull Base Reconstruction · NA · not yet recruiting
NCT07453771 — Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma · NA · not yet recruiting
NCT07404709 — Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Ste · Phase 1, PHASE2 · not yet recruiting
NCT07167342 — The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04976764 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Affiliated Hospital of Qingdao University
Last refreshed: 26 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04976764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing